ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers.

Timothy P DiPeri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.